OnCo

Create your OnCo account

One account keeps your watchlist, saved views and cancer choice in sync across your devices, and lets OnCo alert you when a trial or treatment you follow changes. No password: we email you a sign-in link.

Account creation is being switched on. Until then, press Watch on any page and your list stays in this browser.

Relapsed or refractory multiple myeloma

What changed: Relapsed or refractory multiple myeloma

Cancer page →

Every dated change on the records linked to Relapsed or refractory multiple myeloma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval6Regulatory1Trial result11Milestone7This record1
FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2025 · 3

April 2024 · 1

2024 · 4

2023 · 4

2022 · 3

2021 · 2

2020 · 2

2015 · 2

2012 · 2

2003 · 2